Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven H Lin

Showing results (151-160 of 328) with videos related to

Pageof 33
Sort By:
International Journal of Radiation Oncology, Biology, Physics|April 17, 2012
Prognostic impact of radiation therapy to the primary tumor in patients with non-small cell lung cancer and oligometastasis at diagnosisJose Luis Lopez Guerra, Daniel Gomez, Yan Zhuang, et al.
International Journal of Radiation Oncology, Biology, Physics|April 24, 2026
FLASH Radiotherapy Mitigates Radiation-Induced Lymphopenia and Prevents Immunosuppression via Chk1-STAT3 Axis Modulation in a Preclinical Thoracic Irradiation ModelRong-Hua Tao, Kevin Liu, Edgardo Aguilar, et al.
International Journal of Radiation Oncology, Biology, Physics|August 18, 2017
Lymphocyte Nadir and Esophageal Cancer Survival Outcomes After Chemoradiation TherapyRajayogesh Davuluri, Wen Jiang, Penny Fang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 13, 2014
A high content clonogenic survival drug screen identifies mek inhibitors as potent radiation sensitizers for KRAS mutant non-small-cell lung cancerSteven H Lin, Jing Zhang, Uma Giri, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 12, 2016
The value of <sup>18</sup>F-FDG PET before and after induction chemotherapy for the early prediction of a poor pathologic response to subsequent preoperative chemoradiotherapy in oesophageal adenocarcinomaPeter S N van Rossum, David V Fried, Lifei Zhang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 4, 2020
Alternative Multidisciplinary Management Options for Locally Advanced NSCLC During the Coronavirus Disease 2019 Global PandemicSameera Kumar, Steven Chmura, Clifford Robinson, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 2017
Analysis of Factors Affecting Successful Clinical Trial Enrollment in the Context of Three Prospective, Randomized, Controlled TrialsJennifer K Logan, Chad Tang, Zhongxing Liao, et al.
Clinical Lung Cancer|May 13, 2019
Impact of Corticosteroid Administration on Outcomes Following Stereotactic Ablative Radiotherapy for Non-small-cell Lung CancerHongqi Li, Vivek Verma, Eric D Brooks, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 4, 2014
Serum inflammatory miRNAs predict radiation esophagitis in patients receiving definitive radiochemotherapy for non-small cell lung cancerTing Xu, Zhongxing Liao, Michael S O'Reilly, et al.
The Annals of Thoracic Surgery|July 20, 2014
Signet ring cells in esophageal adenocarcinoma predict poor response to preoperative chemoradiationViren R Patel, Wayne L Hofstetter, Arlene M Correa, et al.
Pageof 33

Showing results (151-160 of 328) with videos related to

Sort By:
Pageof 33
International Journal of Radiation Oncology, Biology, Physics|April 17, 2012
Prognostic impact of radiation therapy to the primary tumor in patients with non-small cell lung cancer and oligometastasis at diagnosisJose Luis Lopez Guerra, Daniel Gomez, Yan Zhuang, et al.
International Journal of Radiation Oncology, Biology, Physics|April 24, 2026
FLASH Radiotherapy Mitigates Radiation-Induced Lymphopenia and Prevents Immunosuppression via Chk1-STAT3 Axis Modulation in a Preclinical Thoracic Irradiation ModelRong-Hua Tao, Kevin Liu, Edgardo Aguilar, et al.
International Journal of Radiation Oncology, Biology, Physics|August 18, 2017
Lymphocyte Nadir and Esophageal Cancer Survival Outcomes After Chemoradiation TherapyRajayogesh Davuluri, Wen Jiang, Penny Fang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 13, 2014
A high content clonogenic survival drug screen identifies mek inhibitors as potent radiation sensitizers for KRAS mutant non-small-cell lung cancerSteven H Lin, Jing Zhang, Uma Giri, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 12, 2016
The value of <sup>18</sup>F-FDG PET before and after induction chemotherapy for the early prediction of a poor pathologic response to subsequent preoperative chemoradiotherapy in oesophageal adenocarcinomaPeter S N van Rossum, David V Fried, Lifei Zhang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 4, 2020
Alternative Multidisciplinary Management Options for Locally Advanced NSCLC During the Coronavirus Disease 2019 Global PandemicSameera Kumar, Steven Chmura, Clifford Robinson, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 2017
Analysis of Factors Affecting Successful Clinical Trial Enrollment in the Context of Three Prospective, Randomized, Controlled TrialsJennifer K Logan, Chad Tang, Zhongxing Liao, et al.
Clinical Lung Cancer|May 13, 2019
Impact of Corticosteroid Administration on Outcomes Following Stereotactic Ablative Radiotherapy for Non-small-cell Lung CancerHongqi Li, Vivek Verma, Eric D Brooks, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 4, 2014
Serum inflammatory miRNAs predict radiation esophagitis in patients receiving definitive radiochemotherapy for non-small cell lung cancerTing Xu, Zhongxing Liao, Michael S O'Reilly, et al.
The Annals of Thoracic Surgery|July 20, 2014
Signet ring cells in esophageal adenocarcinoma predict poor response to preoperative chemoradiationViren R Patel, Wayne L Hofstetter, Arlene M Correa, et al.
Pageof 33